Presence of DNA in oncogenic riboviruses
Emanoïl-Ravicovitch, R.
Pathologie-Biologie 19(21): 1003-1006
1971
ISSN/ISBN: 0369-8114 PMID: 4334316 Document Number: 32876
Document emailed within 1 workday
Related Documents
Miller, E.M. 1998: Fertility and a mate's signals of continued presence - La fertilité et les signaux d'accouplement en présence continue Mankind Quarterly 38(3): 237-278Poeschl, S.; Doering, N. 2015: Measuring Co-Presence and Social Presence in Virtual Environments - Psychometric Construction of a German Scale for a Fear of Public Speaking Scenario Studies in Health Technology and Informatics 219: 58-63
Gallo, R.C.; Todaro, G.J. 1976: Oncogenic RNA viruses Seminars in Oncology 3(1): 81-95
Mohammad, M.A.-A.; Zawilla, N.H.; El-Anwar, F.M.; Aly, S.M.E.-m. 2007: Column and thin-layer chromatographic methods for the simultaneous determination of acediasulfone in the presence of cinchocaine, and cefuroxime in the presence of its hydrolytic degradation products Journal - Association of Official Analytical Chemists 90(2): 405-413
Pérez-Ortiz, L.; Zaldívar-Vaillant, T.; Tamayo-Suárez, J.D. 2000: Malignant gliomas. Oncogenic considerations Revista de Neurologia 31(1): 49-52
Du Pasquier, P.; Grimont, P.; Auriol, J.C. 1972: RNA oncogenic viruses and malignant transformation Bordeaux Medical 5(7): 753-762
Hatanaka, M. 1990: Oncogenic transformation by the tax gene of HTLV-I Nihon Rinsho. Japanese Journal of Clinical Medicine 48(10): 2431-2441
Miller, R.C.; Lanasa, P.; Hanson, W.R. 1997: Misoprostol: a potent cytotoxic and oncogenic radioprotector Advances in Experimental Medicine and Biology 400b: 861-864
Gordon, J.; Krynska, B.; Otte, J.; Houff, S.A.; Khalili, K. 1998: Oncogenic potential of human neurotropic papovavirus, JCV, in CNS Developments in Biological Standardization 94: 93-101
Leone, G. 1973: Notes on the mode of action of oncogenic viruses Archivio Per le Scienze Mediche 130(2): 158-168
Winston, J.T.; Coats, S.R.; Wang, Y.Z.; Pledger, W.J. 1996: Regulation of the cell cycle machinery by oncogenic ras Oncogene 12(1): 127-134
Sakai, T.; Fukuda, I. 2008: Treatment for oncogenic emergencies of the cardiovascular system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(13): 2307-2310
McCuen, R.W.; Stöhrer, G.; Sirotnak, F.M. 1974: Mutagenicity of derivatives of the oncogenic purine N-oxides Cancer Research 34(2): 378-384
Zurawel, R.H.; Chiappa, S.A.; Allen, C.; Raffel, C. 1998: Sporadic medulloblastomas contain oncogenic beta-catenin mutations Cancer Research 58(5): 896-899
Petralia, S.; Soprano, K.J.; Pochron, S.; Darzynkiewicz, Z.; Traganos, F.; Baserga, R. 1980: Increase in cellular RNA in cells infected with DNA oncogenic viruses Cancer Research 40(9): 3177-3180
Zavizion, B.A.; Naroditskiĭ, B.S.; Grodnitskaia, N.A.; Makhov, A.M.; Tikhonenko, T.I. 1982: Effect of nuclease S1 on DNA of the highly oncogenic simian adenovirus SA7(C8) Molekuliarnaia Biologiia 16(3): 569-574
Theile, M.; Scherneck, S.; Waehlte, H.; Geissler, E. 1983: Are transforming and mutagenic activities of oncogenic papovaviruses correlated? Archiv für Geschwulstforschung 53(3): 227-237
Burger, A.M.; Grugel, R.; Landberg, Göran.; Kitching, R.; Seth, A. 2003: The breast cancer-associated gene Di12 has oncogenic activity Anticancer Research 23(3a): 2027-2033
Vigier, P.; Biquard, J.M.; Krycève-Martinerie, C.; Lawrence, D. 1980: Mechanism(s) of neoplastic transformation by avian oncogenic retroviruses Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 174(4): 627-637
Fenton, R.G.; Hixon, J.A.; Wright, P.W.; Brooks, A.D.; Sayers, T.J. 1998: Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras Cancer Research 58(15): 3391-3400